C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Schlotter, C. M. | |
dc.contributor.author | Vogt, U. | |
dc.contributor.author | Bosse, U. | |
dc.contributor.author | Mersch, Berthold | |
dc.contributor.author | Waβmann, Katja | |
dc.date.accessioned | 2023-07-11T11:28:01Z | - |
dc.date.available | 2023-07-11T11:28:01Z | - |
dc.date.issued | 2003 | |
dc.identifier.uri | http://osnascholar.ub.uni-osnabrueck.de/handle/unios/70094 | - |
dc.subject | Internal medicine | |
dc.subject | Oncology | |
dc.subject | Breast cancer | |
dc.subject | Biology | |
dc.subject | Ecology | |
dc.subject | Univariate analysis | |
dc.subject | Tamoxifen | |
dc.subject | Multivariate analysis | |
dc.subject | Grading (engineering) | |
dc.subject | Medicine | |
dc.subject | Cyclophosphamide | |
dc.subject | Chemotherapy | |
dc.subject | Epirubicin | |
dc.subject | Surgical oncology | |
dc.subject | Trastuzumab | |
dc.subject | Cancer | |
dc.title | C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer | |
dc.type | journal article | |
dc.identifier.doi | https://doi.org/10.1186/bcr568 | |
dc.description.volume | 5 | |
dc.description.issue | 2 | |
dc.identifier.external | https://openalex.org/W2124402563 | |
dcterms.oaStatus | true | |
local.import.sourcefile | openalex_20230710.ris | |
local.rawaffiliation | null |